Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
KKISSEI PHARMACEUTICAL CO.,LTD. logo
4547TSE Prime

KISSEI PHARMACEUTICAL CO.,LTD.

キッセイ薬品工業 Yahoo Finance

Recent & upcoming events

Jul 31
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 22
Shareholder meeting 21:00
Shareholders' meeting
Venue: キッセイ薬品工業 本社会議室, 長野県松本市芳野19番48号 Details
Add to Google Calendar
May 11
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Oct 23
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar
2027
Jan 8
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Apr 2
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Jun 18
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥97.41B YoY +10.3%
Operating income ¥-2.93B margin -3.0%
Net income ¥13.78B YoY +15.2%
EPS ¥332 YoY +20.9%
P/E —
ROE 6.3% Equity ratio 84% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥88.70B -8.9%
Operating income ¥2.00B —
Net income ¥13.30B -3.5%
EPS ¥327 -1.4%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY25 Q2
Revenue ¥19.31B¥17.66B¥20.88B¥17.72B——
Operating income ¥1.63B¥382M¥2.15B¥-148M——
Net income ¥3.32B¥2.43B¥2.69B¥2.84B——
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

創業家 4.1%事業法人 5.2%国内機関 24.8%個人 6.7%未開示 56.6%202120222023202420252026
創業家事業法人国内機関海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

日本マスタートラスト信託銀行株式会社 12.1%日本マスタートラスト信託銀行株式会社(信託口)株式会社八十二長野銀行(常任代理人 5%株式会社八十二長野銀行(常任代理人 日本マスタートラスト信託銀行株式会社)株式会社日本カストディ銀行（信託口） 4.4%株式会社日本カストディ銀行（信託口）有限会社カンザワ 4.1%有限会社カンザワ神澤 陸雄 3.7%神澤 陸雄第一生命保険株式会社(常任代理人 株 3.2%第一生命保険株式会社(常任代理人 株式会社日本カストディ銀行)鍋林株式会社 3%鍋林株式会社キッセイグループ従業員持株会 2.9%キッセイグループ従業員持株会塩野義製薬株式会社 2.2%塩野義製薬株式会社202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
日本マスタートラスト信託銀行株式会社(信託口) 5,033,000 12.1% Yuho (EDINET)
株式会社八十二長野銀行 2,063,000 5.0% Yuho (EDINET)
株式会社日本カストディ銀行（信託口） 1,840,000 4.4% Yuho (EDINET)
有限会社カンザワ 1,678,000 4.1% Yuho (EDINET)
神澤 陸雄 1,550,000 3.7% Yuho (EDINET)
第一生命保険株式会社 1,344,000 3.2% Yuho (EDINET)
鍋林株式会社 1,222,000 3.0% Yuho (EDINET)
キッセイグループ従業員持株会 1,212,000 2.9% Yuho (EDINET)
STATE STREET BANK AND TRUST COMPANY 505103 1,112,000 2.7% Yuho (EDINET)
塩野義製薬株式会社 914,000 2.2% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

3/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 5.0%
✗ Positive operating cash flow ¥-1.49B
✓ ROA improved YoY 4.9% → 5.0%
✗ Operating CF exceeds net income (accrual quality) OCF ¥-1.49B / net income ¥13.78B
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 85.6% → 83.7%
✗ Current ratio improved 6.45× → 5.30×
✓ No dilution (shares outstanding did not increase) 47,911,185 → 46,541,985
✗ Gross margin improved 49.9% → 47.0%
✗ Asset turnover improved 0.36× → 0.35×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 83.7%
Current ratio 5.3×
Years of positive operating CF 6 of last 10 yrs
Payout ratio 53%
Latest fiscal year result Profit (net income ¥13.78B)

Performance history

Last 10 years
0億円244億円487億円731億円974億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 717740723632690654675756883974
Operating income 84.998.962.018.615.1-14.0-11.340.257.7-29.3
Ordinary income 96.411471.724.334.85.625.9861.469.7-11.6
Net income 77.390.554.828.252.9129105112120138
Total assets 1,8682,1312,1352,3182,6892,3812,2122,6092,4412,751
Equity 1,5781,7611,8271,9302,2002,0221,9482,2112,1012,315

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥159¥188¥117¥60¥113¥280¥228¥247¥274¥332
ROE 4.9%5.4%3.1%1.5%2.6%6.1%5.3%5.4%5.6%6.3%
Operating CF 64.488.563.5139-25.415.3-66.8-16.865.2-14.9
Investing CF -46.7-29.6-20.94.90-93.310860.086.949.5175
Financing CF -37.7-66.2-23.1-44.2-40.0-27.6-34.2-100-93.3-103
FCF 17.758.942.6144-119123-6.7870.1115160

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓ Dividend grower ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data